Cerebral venous thrombosis in adults: The role of imaging evaluation and management

Neuroimaging Clinics of North America

Volumn 13, Issue 1, 2003, Pages 139-152

  Lee, Seon Kyu ^a   TerBrugge, Karel G ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b TORONTO WESTERN HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN;

ADULT; ANTICOAGULANT THERAPY; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BRAIN EDEMA; BRAIN HEMORRHAGE; CEREBRAL SINUS THROMBOSIS; CEREBRAL VENOUS THROMBOSIS; CLINICAL FEATURE; COLLATERAL CIRCULATION; CONSCIOUSNESS DISORDER; CRANIAL NERVE PARALYSIS; DEEP VEIN THROMBOSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIFFUSION COEFFICIENT; DIFFUSION IMAGING; DISEASE COURSE; ENDOVASCULAR SURGERY; FEMALE; FIBRINOLYTIC THERAPY; HEADACHE; HEPARINIZATION; HUMAN; INFARCTION; MAJOR CLINICAL STUDY; MALE; NAUSEA; NEUROIMAGING; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; NYSTAGMUS; PAPILLEDEMA; PRIORITY JOURNAL; PROGNOSIS; SEIZURE; SENSITIVITY AND SPECIFICITY; THROMBUS; TREATMENT OUTCOME; VEIN OCCLUSION; VEIN THROMBOSIS; VENOUS INFARCTION; VISUAL DISORDER; VOMITING;

EID: 0037301579     PISSN: 10525149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1052-5149(02)00095-3     Document Type: Article

References (44)

1. Lee SK, Kim BS, Terbrugge K. Clinical presentation, imaging and treatment of cerebral venous thrombosis (CVT). Intervent Neuroradiol 2002;8:5-14.
2. Bousser MG. Cerebral venous thrombosis: diagnosis and management. J Neurol 2000;247:252-8.
3. Einhaupl KM, Villringer A, Meister W, et al. Heparin treatment in sinus venous thrombosis. Lancet 1991; 338:597-600.
4. Ameri A, Bousser MG. Cerebral venous thrombosis. Neurol Clin 1992;10:87-111.
5. Bousser MG. Cerebral venous thrombosis: nothing, heparin, or local thrombolysis? Stroke 1999;30:481-3.
6. Martinelli I, Sacchi E, Landi G, et al. High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives. N Engl J Med 1998;338:1793-7.
7. Seligsohn U, Lubetsky A. Genetic susceptibility to venous thrombosis. N Engl J Med 2001;344:1222-31.
8. de Bruijn SF, Stam J. Randomized, placebo-controlled trial of anticoagulant treatment with low-molecular-weight heparin for cerebral sinus thrombosis. Stroke 1999;30:484-8.
9. Brucker AB, Vollert-Rogenhofer H, Wagner M, et al. Heparin treatment in acute cerebral sinus venous thrombosis: a retrospective clinical and MR analysis of 42 cases. Cerebrovasc Dis 1998;8:331-7.
10. Cantu C, Barinagarrementeria F. Cerebral venous thrombosis associated with pregnancy and puerperium. Review of 67 cases. Stroke 1993;24:1880-4.
11. Tsai FY, Wang AM, Matovich VB, et al. MR staging of acute dural sinus thrombosis: correlation with venous pressure measurements and implications for treatment and prognosis. AJNR Am J Neuroradiol 1995;16: 1021-9.
12. Frerichs KU, Deckert M, Kempski O, et al. Cerebral sinus and venous thrombosis in rats induces long-term deficits in brain function and morphology - evidence for a cytotoxic genesis. J Cereb Blood Flow Metab 1994;14:289-300.
13. Kanaiwa H, Kuchiwaki H, Inao S, et al. Changes in the cerebrocortical capillary network following venous sinus occlusion in cats. Surg Neurol 1995;44: 172-9.
14. Rother J, Waggie K, van Bruggen N, et al. Experimental cerebral venous thrombosis: evaluation using magnetic resonance imaging. J Cereb Blood Flow Metab 1996;16:1353-61.
15. Nakase H, Kakizaki T, Miyamoto K, et al. Use of local cerebral blood flow monitoring to predict brain damage after disturbance to the venous circulation: cortical vein occlusion model by photochemical dye. Neurosurgery 1995;37:280-5.
16. Ducreux D, Oppenheim C, Vandamme X, et al. Diffusion-weighted imaging patterns of brain damage associated with cerebral venous thrombosis. AJNR Am J Neuroradiol 2001;22:261-8.
17. Forbes KP, Pipe JG, Heiserman JE. Evidence for cytotoxic edema in the pathogenesis of cerebral venous infarction. AJNR Am J Neuroradiol 2001;22:450-5.
18. Lovblad KO, Baird AE, Schlaug G, et al. Ischemic lesion volumes in acute stroke by diffusion-weighted magnetic resonance imaging correlate with clinical outcome. Ann Neurol 1997;42:164-70.
19. Kuwahara S, Abe T, Kawada M, et al. A case of cerebral venous thrombosis with reversible brain parenchymal lesions: usefulness of diffusion weighted imaging and measurement of apparent diffusion coefficient [in Japanese]. No To Shinkei 2001;53: 79-83.
20. Ogami R, Ikawa F, Kiura Y, et al. Diagnosis of acute phase of venous infarction by diffusion-weighted image: case report and review of the literature [in Japanese]. No To Shinkei 2001;53:979-83.
21. Manzione J, Newman GC, Shapiro A, et al. Diffusion and perfusion weighted MR imaging of dural sinus thrombosis. AJNR Am J Neuroradiol 2000; 21:68-73.
22. Willinsky R, Goyal M, Terbrugge K, et al. Tortuous, engorged pial veins in intracranial dural arteriovenous fistulas: correlations with presentation, location, and MR findings in 122 patients. AJNR Am J Neuroradiol 1999;20:1031-6.
23. Benamer HT, Bone I. Cerebral venous thrombosis: anticoagulants or thrombolyic therapy. J Neurol Neurosurg Psychiatry 2000;69:427-30.
24. Frey JL, Muro GJ, McDougall CG, et al. Cerebral venous thrombosis: combined intrathrombus rtPA and intravenous heparin. Stroke 1999;30:489-94.
25. Barnwell SL, Higashida RT, Halbach VV, et al. Direct endovascular thrombolytic therapy for dural sinus thrombosis. Neurosurgery 1991;28:135-42.
26. Chaloupka JC, Mangla S, Huddle DC. Use of mechanical thrombolysis via microballoon percutaneous transluminal angioplasty for the treatment of acute dural sinus thrombosis: case presentation and technical report. Neurosurgery 1999;45:650-6.
27. Ekseth K, Bostrom S, Vegfors M. Reversibility of severe sagittal sinus thrombosis with open surgical thrombectomy combined with local infusion of tissue plasminogen activator: technical case report. Neurosurgery 1998;43:960-5.
28. Higashida RT, Helmer E, Halbach VV, et al. Direct thrombolytic therapy for superior sagittal sinus thrombosis. AJNR Am J Neuroradiol 1989;10(Suppl 5): S4-6.
29. Horowitz M, Purdy P, Unwin H, et al. Treatment of dural sinus thrombosis using selective catheterization and urokinase. Ann Neurol 1995;38:58-67.
30. Malek AM, Higashida RT, Balousek PA, et al. Endovascular recanalization with balloon angioplasty and stenting of an occluded occipital sinus for treatment of intracranial venous hypertension: technical case report. Neurosurgery 1999;44:896-901.
31. Scarrow AM, Williams RL, Jungreis CA, et al. Removal of a thrombus from the sigmoid and transverse sinuses with a rheolytic thrombectomy catheter. AJNR Am J Neuroradiol 1999;20:1467-9.
32. Scott JA, Pascuzzi RM, Hall PV, et al. Treatment of dural sinus thrombosis with local urokinase infusion. Case report. J Neurosurg 1988;68:284-7.
33. Smith TP, Higashida RT, Barnwell SL, et al. Treatment of dural sinus thrombosis by urokinase infusion. AJNR Am J Neuroradiol 1994;15:801-7.
34. Söderman M, Johnsson H, Ericson K, et al. Acutesinus thrombosis in a child with antibodies against cardiolipins. Intervent Neuroradiol 1996;2:143-8.
35. Tsai FY, Higashida RT, Matovich V, et al. Acute thrombosis of the intracranial dural sinus: direct thrombolytic treatment. AJNR Am J Neuroradiol 1992;13:1137-41.
36. Vines FS, Davis DO. Clinical-radiological correlation in cerebral venous occlusive disease. Radiology 1971;98:9-22.
37. Villringer A, Mehraein S, Einhaupl KM. Pathophysiological aspects of cerebral sinus venous thrombosis (SVT). J Neuroradiol 1994;21:72-80.
38. Stam J, Lensing AW, Vermeulen M, et al. Heparin treatment for cerebral venous and sinus thrombosis. Lancet 1991;338:597-600.
39. Holder CA, Bell DA, Lundell AL, et al. Isolated straight sinus and deep cerebral venous thrombosis: successful treatment with local infusion of urokinase. Case report. J Neurosurg 1997;86:704-7.
40. Spearman MP, Jungreis CA, Wehner JJ, et al. Endovascular thrombolysis in deep cerebral venous thrombosis. AJNR Am J Neuroradiol 1997;18:502-6.
41. Kim SY, Suh JH. Direct endovascular thrombolytic therapy for dural sinus thrombosis: infusion of alteplase. AJNR Am J Neuroradiol 1997;18:639-45.
42. Eisenberg PR, Sherman LA, Tiefenbrunn AJ, et al. Sustained fibrinolysis after administration of t-PA despite its short half-life in the circulation. Thromb Haemost 1987;57:35-40.
43. Sobel BE, Gross RW, Robison AK. Thrombolysis, clot selectivity, and kinetics. Circulation 1984;70:160-4.
44. Vilela P, Willinsky R, Terbrugge K. Treatment ofintracranial venous occlusive disease with sigmoid sinus angioplasty and stent placement in a case of infantile multifocal dural arteriovenous shunts. Intervent Neuroradiol 2001;7:51-60.